Clinical Experience with Adalimumab in the Treatment of Ocular Behçet Disease

By Bawazeer Ahmed   Raffa Lina H.   given-names given-names Nizamuddin  

Ocular Immunology and Inflammation, Vol. 18, Iss. 3, 2010-06 ,pp. : 226-232

Informa Healthcare

Access to resources Recommend Favorite

Demographic, Clinical, and Ocular Features in Patients with Late-onset Behçet Disease

By Hazirolan Dicle   Sungur Gulten   Duman Sunay  

Ocular Immunology and Inflammation, Vol. 20, Iss. 2, 2012-04 ,pp. : 119-124

Informa Healthcare

Access to resources Recommend Favorite

Ocular Pulse Amplitude in Behçet Disease

By Çetin Ebru Nevin   Bulgu Yunus   Taslıı Levent   Çobankara Veli   Yildirıım Cem  

Ocular Immunology and Inflammation, Vol. 19, Iss. 5, 2011-10 ,pp. : 376-378

Informa Healthcare

Access to resources Recommend Favorite

Behçet's disease in Western Switzerland: Epidemiology and analysis of ocular involvement

By Ambresin A.   Tao Tran V.   Spertini François   Herbort Carl P.  

Ocular Immunology and Inflammation, Vol. 10, Iss. 1, 2002-03 ,pp. : 53-63

Informa Healthcare

Access to resources Recommend Favorite

The demonstration of serum interleukin 6–8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement

By Bardak Yavuz   Aridogan Buket Cicioglu  

Ocular Immunology and Inflammation, Vol. 12, Iss. 1, 2004-03 ,pp. : 53-58

Informa Healthcare

Access to resources Recommend Favorite